Locations:
Search IconSearch

Research

Case Study in Collaboration: Decreasing Prolonged Post-CABG Ventilation Rates
June 4, 2021/Cancer/Research

Mechanical Ventilation Rates in Oncology Patients with COVID-19

Low rates raise questions about eligibility for intervention

19-CNR-4145 Merkel cell carcinoma 650×450
April 15, 2021/Cancer/Research

New Cell Therapies May Hold Key to Treatment of Advanced and Rare Skin Cancers

Tumor-infiltrating lymphocytes and natural killer cells

Blood Clot Cell Artery
March 24, 2021/Cancer/Research

Venous Thromboembolism Common in Cancer Patients Treated with Immunotherapy

An underappreciated immune-related adverse event

17-PUL-4838-Mazzone-Hero-Image-650x450pxl
March 1, 2021/Cancer/Research

New Society Guidelines for Tissue Procurement in Immuno-oncology Clinical Trials

Parameters for the collection and management of biospecimens

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

QD ASH 2020 Top Abstracts CQD Graphic (1)
February 16, 2021/Cancer/Research

Top Abstracts To Watch: ASH 2020

These research results will have impact in 2021

20-NUR-1892057-NN-Big-Data-CQD-650×450
December 7, 2020/Cancer/Research

Cleveland Clinic’s Cancer Research Team Sees Increased Productivity During COVID-19

Working from home leads to more efficiency, job satisfaction for research coordinators

leukemia_650x450

Succession of Molecular Lesions Critical to Leukemia Disease Development

Mutational pattern in MDS is not random, study finds

19-NEU-6528_brain-tumor_650x450
June 25, 2020/Cancer/Research

Phase II Trial Evaluates Safety of Pembrolizumab plus SurVaxM in Recurrent Glioblastoma

Will cancer vaccine boost immunotherapy’s efficacy?

BackPage 12 of 42Next

Advertisement

Ad